# Motor neurone disease

1 posts.

- [NuNerve's MND drug NUN-004 faces its first placebo-controlled test after early signs of stabilising disease](https://healthcarenews.io/news/nun-004-phase-2-trial-mnd-placebo-test.md) (2026-11-10): NuNerve's NUN-004 Phase 2 trial will test the MND drug against placebo in 75 people across six Australian sites, after a small open-label first study.